Caricamento...
Serum CYR61 as a potential biomarker for the diagnosis of esophagogastric junction tumor
Background: Esophagogastric junction tumor (EGJ) is a rare but fatal disease with a rapid rising incidence worldwide in the late 20 years, and it lacks a convenient and safe method for diagnosis. The present study aimed to evaluate the potential of serum CYR61 as a biomarker for the diagnosis of EGJ...
Salvato in:
| Pubblicato in: | Biosci Rep |
|---|---|
| Autori principali: | , , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Portland Press Ltd.
2021
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8217984/ https://ncbi.nlm.nih.gov/pubmed/34085702 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1042/BSR20204117 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|